Latest Insider Transactions at Krystal Biotech, Inc. (KRYS)
This section provides a real-time view of insider transactions for Krystal Biotech, Inc. (KRYS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Krystal Biotech, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Krystal Biotech, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2025
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
25,000
-0.32%
|
$4,425,000
$177.72 P/Share
|
|
Mar 13
2025
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
25,000
-0.34%
|
$4,425,000
$177.76 P/Share
|
|
Mar 13
2025
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.34%
|
$4,425,000
$177.76 P/Share
|
|
Mar 13
2025
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-0.32%
|
$4,425,000
$177.72 P/Share
|
|
Feb 28
2025
|
Suma Krishnan President, R&D |
SELL
Payment of exercise price or tax liability
|
Indirect |
21,985
-0.47%
|
$3,935,315
$179.25 P/Share
|
|
Feb 28
2025
|
Suma Krishnan President, R&D |
BUY
Exercise of conversion of derivative security
|
Indirect |
47,500
+1.0%
|
-
|
|
Feb 28
2025
|
Suma Krishnan President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
13,885
-0.46%
|
$2,485,415
$179.25 P/Share
|
|
Feb 28
2025
|
Suma Krishnan President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+0.99%
|
-
|
|
Feb 28
2025
|
Kathryn Romano Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,786
-14.19%
|
$1,035,694
$179.25 P/Share
|
|
Feb 28
2025
|
Kathryn Romano Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+23.44%
|
-
|
|
Feb 28
2025
|
Krish S Krishnan President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
13,885
-0.46%
|
$2,485,415
$179.25 P/Share
|
|
Feb 28
2025
|
Krish S Krishnan President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
30,000
+0.99%
|
-
|
|
Feb 28
2025
|
Krish S Krishnan President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,985
-0.47%
|
$3,935,315
$179.25 P/Share
|
|
Feb 28
2025
|
Krish S Krishnan President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
47,500
+1.0%
|
-
|
|
Feb 27
2025
|
Kathryn Romano Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
750
-5.62%
|
$131,250
$175.22 P/Share
|
|
Feb 26
2025
|
Suma Krishnan President, R&D |
SELL
Payment of exercise price or tax liability
|
Indirect |
4,721
-0.3%
|
$830,896
$176.39 P/Share
|
|
Feb 26
2025
|
Suma Krishnan President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
3,286
-0.22%
|
$578,336
$176.39 P/Share
|
|
Feb 26
2025
|
Kathryn Romano Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,268
-14.52%
|
$399,168
$176.39 P/Share
|
|
Feb 26
2025
|
Krish S Krishnan President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,286
-0.22%
|
$578,336
$176.39 P/Share
|
|
Feb 26
2025
|
Krish S Krishnan President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,721
-0.31%
|
$830,896
$176.39 P/Share
|
|
Dec 13
2024
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.19%
|
$4,175,000
$167.16 P/Share
|
|
Dec 13
2024
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-0.2%
|
$4,175,000
$167.05 P/Share
|
|
Dec 13
2024
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
25,000
-0.2%
|
$4,175,000
$167.05 P/Share
|
|
Dec 13
2024
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
25,000
-0.19%
|
$4,175,000
$167.16 P/Share
|
|
Sep 13
2024
|
Dino A Rossi Director |
SELL
Bona fide gift
|
Direct |
5,000
-5.97%
|
-
|
|
Sep 12
2024
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
25,000
-0.2%
|
$4,950,000
$198.48 P/Share
|
|
Sep 12
2024
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
25,000
-0.24%
|
$4,950,000
$198.38 P/Share
|
|
Sep 12
2024
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.24%
|
$4,950,000
$198.38 P/Share
|
|
Sep 12
2024
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-0.2%
|
$4,950,000
$198.48 P/Share
|
|
Jun 11
2024
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.2%
|
$4,350,000
$174.85 P/Share
|
|
Jun 11
2024
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-0.2%
|
$4,375,000
$175.06 P/Share
|
|
Jun 11
2024
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
25,000
-0.2%
|
$4,375,000
$175.06 P/Share
|
|
Jun 11
2024
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
25,000
-0.2%
|
$4,350,000
$174.85 P/Share
|
|
May 20
2024
|
Julian S Gangolli Director |
SELL
Open market or private sale
|
Direct |
20,000
-77.61%
|
$3,280,000
$164.6 P/Share
|
|
May 20
2024
|
Julian S Gangolli Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$440,000
$22.75 P/Share
|
|
Mar 11
2024
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
25,000
-0.22%
|
$4,275,000
$171.04 P/Share
|
|
Mar 11
2024
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
25,000
-0.23%
|
$4,275,000
$171.18 P/Share
|
|
Mar 11
2024
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.23%
|
$4,275,000
$171.18 P/Share
|
|
Mar 11
2024
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-0.22%
|
$4,275,000
$171.04 P/Share
|
|
Feb 28
2024
|
Kathryn Romano Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,314
-12.9%
|
$377,182
$163.08 P/Share
|
|
Feb 28
2024
|
Kathryn Romano Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+4.45%
|
$1,050,000
$60.9 P/Share
|
|
Feb 28
2024
|
Kathryn Romano Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
12,500
-3.93%
|
$2,075,000
$166.99 P/Share
|
|
Feb 28
2024
|
Suma Krishnan President, R&D |
SELL
Payment of exercise price or tax liability
|
Indirect |
5,785
-0.35%
|
$942,955
$163.08 P/Share
|
|
Feb 28
2024
|
Suma Krishnan President, R&D |
BUY
Exercise of conversion of derivative security
|
Indirect |
12,500
+0.76%
|
-
|
|
Feb 28
2024
|
Suma Krishnan President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
3,471
-0.22%
|
$565,773
$163.08 P/Share
|
|
Feb 28
2024
|
Suma Krishnan President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+0.47%
|
-
|
|
Feb 28
2024
|
Krish S Krishnan President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,471
-0.22%
|
$565,773
$163.08 P/Share
|
|
Feb 28
2024
|
Krish S Krishnan President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
7,500
+0.47%
|
-
|
|
Feb 28
2024
|
Krish S Krishnan President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,785
-0.35%
|
$942,955
$163.08 P/Share
|
|
Feb 28
2024
|
Krish S Krishnan President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+0.76%
|
-
|